The Role of Biomarkers in the Diagnosis and Management of Heart Failure-Juniper Publishers
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Heart failure is a growing challenge both in diagnosis and management globally. Current diagnostic tools have several merits and limitations and the field is in dying need for effective and efficient biomarkers. Emerging biomarkers show promising evidence of revolutionizing the early diagnosis and management of heart failure by cardiologists and non-specialists. Biomarkers are classified according to myocyte changes as such biomarkers in myocyte stress, injury and necrosis, ischemia and fibrosis. In addition, there are biomarkers in heart failure associated with infections, renal dysfunction and neurohormonal biomarkers. This article will briefly discuss key biomarkers with major evidence to galvanize medical field interest in this remarkable field. Keywords: Heart failure; Biomarkers; BNP; NT-proBNP; MR-proANP; MR-proADM; Troponin; GDF-15; Procalcitonin; Gal-3. Abbreviati...